Literature DB >> 15613322

Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease.

Tao Pan1, Poki Wong, Binggong Chang, Chaoyang Li, Ruliang Li, Shin-Chung Kang, Thomas Wisniewski, Man-Sun Sy.   

Abstract

Infection with any one of three strains of mouse scrapie prion (PrPSc), 139A, ME7, or 22L, results in the accumulation of two underglycosylated, full-length PrP species and an N-terminally truncated PrP species that are not detectable in uninfected animals. The levels of the N-terminally truncated PrP species vary depending on PrPSc strain. Furthermore, 22L-infected brains consistently have the highest levels of proteinase K (PK)-resistant PrP species, followed by ME7- and 139A-infected brains. The three strains of PrPSc are equally susceptible to PK and proteases papain and chymotrypsin. Their protease resistance patterns are also similar. In sucrose gradient velocity sedimentation, the aberrant PrP species partition with PrPSc aggregates, indicating that they are physically associated with PrPSc. In ME7-infected animals, one of the underglycosylated, full-length PrP species is detected much earlier than the other, before both the onset of clinical disease and the detection of PK-resistant PrP species. In contrast, the appearance of the N-terminally truncated PrP species coincides with the presence of PK-resistant species and the manifestation of clinical symptoms. Therefore, accumulation of the underglycosylated, full-length PrP species is an early biochemical fingerprint of PrPSc infection. Accumulation of the underglycosylated, full-length PrP species and the aberrant N-terminally truncated PrP species may be important in the pathogenesis of prion disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15613322      PMCID: PMC538529          DOI: 10.1128/JVI.79.2.934-943.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Immunological analysis of host and agent effects on Creutzfeldt-Jakob disease and scrapie prion proteins.

Authors:  J M Bockman; D T Kingsbury
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

2.  Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.

Authors:  P Parchi; R Castellani; S Capellari; B Ghetti; K Young; S G Chen; M Farlow; D W Dickson; A A Sima; J Q Trojanowski; R B Petersen; P Gambetti
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

3.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

Review 4.  The pathogenesis of scrapie in mice.

Authors:  G W Outram
Journal:  Front Biol       Date:  1976

5.  Scrapie prions aggregate to form amyloid-like birefringent rods.

Authors:  S B Prusiner; M P McKinley; K A Bowman; D C Bolton; P E Bendheim; D F Groth; G G Glenner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

6.  Novel differences between two human prion strains revealed by two-dimensional gel electrophoresis.

Authors:  T Pan; M Colucci; B S Wong; R Li; T Liu; R B Petersen; S Chen; P Gambetti; M S Sy
Journal:  J Biol Chem       Date:  2001-08-06       Impact factor: 5.157

7.  Detection of PrP(Sc) in subclinical BSE with the paraffin-embedded tissue (PET) blot.

Authors:  W J Schulz-Schaeffer; R Fatzer; M Vandevelde; H A Kretzschmar
Journal:  Arch Virol Suppl       Date:  2000

8.  Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells.

Authors:  S Lehmann; D A Harris
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

Review 9.  A gene-targeted mouse model of P102L Gerstmann-Sträussler-Scheinker syndrome.

Authors:  Rona M Barron; Jean C Manson
Journal:  Clin Lab Med       Date:  2003-03       Impact factor: 1.935

10.  Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent.

Authors:  R A Bessen; R F Marsh
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more
  16 in total

1.  An aggregation-specific enzyme-linked immunosorbent assay: detection of conformational differences between recombinant PrP protein dimers and PrP(Sc) aggregates.

Authors:  Tao Pan; Binggong Chang; Poki Wong; Chaoyang Li; Ruliang Li; Shin-Chung Kang; John D Robinson; Andrew R Thompsett; Po Tein; Shaoman Yin; Geoff Barnard; Ian McConnell; David R Brown; Thomas Wisniewski; Man-Sun Sy
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

2.  Use of thermolysin in the diagnosis of prion diseases.

Authors:  Jonathan P Owen; Ben C Maddison; Garry C Whitelam; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2007-02       Impact factor: 2.695

3.  Molecular profiling of ovine prion diseases by using thermolysin-resistant PrPSc and endogenous C2 PrP fragments.

Authors:  Jonathan P Owen; Helen C Rees; Ben C Maddison; Linda A Terry; Leigh Thorne; Roy Jackman; Garry C Whitelam; Kevin C Gough
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

4.  Environmentally-relevant forms of the prion protein.

Authors:  Samuel E Saunders; Jason C Bartz; Glenn C Telling; Shannon L Bartelt-Hunt
Journal:  Environ Sci Technol       Date:  2008-09-01       Impact factor: 9.028

5.  Prion protein "gamma-cleavage": characterizing a novel endoproteolytic processing event.

Authors:  Victoria Lewis; Vanessa A Johanssen; Peter J Crouch; Genevieve M Klug; Nigel M Hooper; Steven J Collins
Journal:  Cell Mol Life Sci       Date:  2015-08-23       Impact factor: 9.261

6.  Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.

Authors:  Bradley M Coleman; Christopher F Harrison; Belinda Guo; Colin L Masters; Kevin J Barnham; Victoria A Lawson; Andrew F Hill
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

7.  The region approximately between amino acids 81 and 137 of proteinase K-resistant PrPSc is critical for the infectivity of the Chandler prion strain.

Authors:  Ryo Shindoh; Chan-Lan Kim; Chang-Hyun Song; Rie Hasebe; Motohiro Horiuchi
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

8.  Specific biarsenical labeling of cell surface proteins allows fluorescent- and biotin-tagging of amyloid precursor protein and prion proteins.

Authors:  Yuzuru Taguchi; Zhen-Dan Shi; Brian Ruddy; David W Dorward; Lois Greene; Gerald S Baron
Journal:  Mol Biol Cell       Date:  2008-11-05       Impact factor: 4.138

9.  The polybasic N-terminal region of the prion protein controls the physical properties of both the cellular and fibrillar forms of PrP.

Authors:  Valeriy G Ostapchenko; Natallia Makarava; Regina Savtchenko; Ilia V Baskakov
Journal:  J Mol Biol       Date:  2008-09-04       Impact factor: 5.469

10.  Identification of an intracellular site of prion conversion.

Authors:  Zrinka Marijanovic; Anna Caputo; Vincenza Campana; Chiara Zurzolo
Journal:  PLoS Pathog       Date:  2009-05-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.